What is Kura Oncology, Inc.'s Market Cap?

Kura Oncology, Inc.'s Market Cap is $1.1B, based on as-reported figures from SEC (XBRL) filings.

What is Kura Oncology, Inc.'s Enterprise Value?

Kura Oncology, Inc.'s Enterprise Value is $1.1B, based on as-reported figures from SEC (XBRL) filings.

What is Kura Oncology, Inc.'s Price / Sales?

Kura Oncology, Inc.'s Price / Sales is 14.4×, based on as-reported figures from SEC (XBRL) filings.

What is Kura Oncology, Inc.'s EV / Revenue?

Kura Oncology, Inc.'s EV / Revenue is 13.6×, based on as-reported figures from SEC (XBRL) filings.

What is Kura Oncology, Inc.'s EV / EBITDA?

Kura Oncology, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Kura Oncology, Inc.'s Revenue (TTM)?

Kura Oncology, Inc.'s Revenue (TTM) is $77.2M, based on as-reported figures from SEC (XBRL) filings.

What is Kura Oncology, Inc.'s Net Income (TTM)?

Kura Oncology, Inc.'s Net Income (TTM) is -$296.8M, based on as-reported figures from SEC (XBRL) filings.

What is Kura Oncology, Inc.'s EBITDA?

Kura Oncology, Inc.'s EBITDA is -$316.8M, based on as-reported figures from SEC (XBRL) filings.

What is Kura Oncology, Inc.'s Diluted EPS (TTM)?

Kura Oncology, Inc.'s Diluted EPS (TTM) is -3.34, based on as-reported figures from SEC (XBRL) filings.

What is Kura Oncology, Inc.'s EBITDA Margin?

Kura Oncology, Inc.'s EBITDA Margin is -410.2%, based on as-reported figures from SEC (XBRL) filings.

Kura Oncology, Inc. (KURA) Financial Statements

Kura Oncology, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG008974351

XNAS · usd

12.52▼ 0.73 (-5.51%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close13.25

Day's Range12.50 – 12.93

52-Week Range7.36 – 13.90

Volume1.5M

Avg Volume2.0M

Share Statistics

Shares Outstanding

Employees260

ExchangeXNAS

Listed2015-08-25

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Kura Oncology, Inc. (KURA)

What is Kura Oncology, Inc.'s Market Cap?: Kura Oncology, Inc.'s Market Cap is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Kura Oncology, Inc.'s Enterprise Value?: Kura Oncology, Inc.'s Enterprise Value is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Kura Oncology, Inc.'s Price / Sales?: Kura Oncology, Inc.'s Price / Sales is 14.4×, based on as-reported figures from SEC (XBRL) filings.
What is Kura Oncology, Inc.'s EV / Revenue?: Kura Oncology, Inc.'s EV / Revenue is 13.6×, based on as-reported figures from SEC (XBRL) filings.
What is Kura Oncology, Inc.'s EV / EBITDA?: Kura Oncology, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Kura Oncology, Inc.'s Revenue (TTM)?: Kura Oncology, Inc.'s Revenue (TTM) is $77.2M, based on as-reported figures from SEC (XBRL) filings.
What is Kura Oncology, Inc.'s Net Income (TTM)?: Kura Oncology, Inc.'s Net Income (TTM) is -$296.8M, based on as-reported figures from SEC (XBRL) filings.
What is Kura Oncology, Inc.'s EBITDA?: Kura Oncology, Inc.'s EBITDA is -$316.8M, based on as-reported figures from SEC (XBRL) filings.
What is Kura Oncology, Inc.'s Diluted EPS (TTM)?: Kura Oncology, Inc.'s Diluted EPS (TTM) is -3.34, based on as-reported figures from SEC (XBRL) filings.
What is Kura Oncology, Inc.'s EBITDA Margin?: Kura Oncology, Inc.'s EBITDA Margin is -410.2%, based on as-reported figures from SEC (XBRL) filings.